Dr. Pedro Madureira

Immunothep ; i3S

Pedro Madureira has graduated in Biochemistry at the Faculty of Sciences of the University of Porto (FCUP) and obtained his PhD in Biomedical Sciences at the Instituto de Ciências Biomédicas Abel Salazar (ICBAS) of the same university. The work developed since the beginning of his scientific career follows a line of investigation started a few decades ago by Prof. Mário Arala Chaves, with the discovery of immunosuppressive molecules excreted by bacterial pathogens, so called virulence-associated immunomodulatory proteins (VIP). Currently, his main research interest is the role of a specific VIP in the host-pathogen interactions that are responsible for the high susceptibility of the human host to severe bacterial infections.

Pedro Madureira is the co-founder and CSO of Immunethep, a biotech company focused on the development of anti-bacterial immunotherapies against multi-drug resistant bacteria.